NCT05053776 is a clinical trial in Recurrent Respiratory Tract Infections, sponsored by Remonda Ramsis Hennis.

Who is sponsoring NCT05053776?

NCT05053776 is sponsored by Remonda Ramsis Hennis.

What condition does NCT05053776 study?

NCT05053776 studies Recurrent Respiratory Tract Infections.

Is NCT05053776 still recruiting?

NCT05053776 is currently status unknown. Last updated 22 September 2021.

Last reviewed 2021-09-22 · How we verify

NCT05053776

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Laboratory Predictors of Respiratory Morbidities in CP Children

Status unknown Last updated 22 September 2021

What this trial tests

trial in Recurrent Respiratory Tract Infections in 50 participants. Status unknown.

Timeline

1 October 2021

Primary endpoint
1 October 2022

1 January 2023

Quick facts

Lead sponsor	Remonda Ramsis Hennis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 October 2021
Primary completion	1 October 2022
Estimated completion	1 January 2023

Conditions studied

Recurrent Respiratory Tract Infections — all drugs for Recurrent Respiratory Tract Infections →

Sponsor

Remonda Ramsis Hennis

Who can join

Adults 1 Month to 18, any sex, with Recurrent Respiratory Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Relationship between respiratory morbidities and cerebral palsy in children

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Recurrent Respiratory Tract Infections

Currently open trials in the same condition.

NCT07297966 — Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Y · Phase 2 · recruiting
NCT06201494 — Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05053776 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Remonda Ramsis Hennis
Last refreshed: 22 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05053776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing